Foothill Ventures — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers.
BiotechDeep TechHardwareHealthtechPleasanton, US
Serge Saxonov(Founder)inBen Hindson(Founder)inBrad Crutchfield(Chief Commercial Officer)inJean Philibert(Chief People Officer)Eric S Whitaker(General Counsel)inJustin McAnear(Chief Financial Officer)in
Co-investorsForesite CapitalKhosla VenturesOMX VenturesPaladin Capital GroupSoftBank Vision FundVenrock+4 more
Automation Anywhere provides robotic process automation (RPA), intelligent document processing (IDP), and agentic automation solutions for enterprise customers.
AI & Machine LearningEnterprise SoftwareSaaSSan Jose, US
Mihir Shukla(Founder)inNeeti Mehta Shukla(Founder)inAnkur Kothari(Founder)inClyde Hosein(Executive Officer)inNancy HaugeinNeeti Mehta(Founder)
Co-investors1435 CapitalAxevil CapitalBell VenturesCollective LiquidityEmpede CapitalEniac Ventures+18 more
Bubble is an AI-powered no-code development platform that lets users build full-stack web and native mobile applications through AI prompting and a visual editor, with built-in database, authentication, hosting, and scaling.
AI & Machine LearningDeveloper ToolsSaaS
Emmanuel Straschnov(Founder)inJosh Haas(Founder)inShai Eisenman(Founder)
Co-investorsBoxGroupColor CapitalDig Ventures Management LimitedIrregular ExpressionsKima VenturesNewView Capital+4 more
Celero Systems is developing an ingestible pill-based platform that monitors cardiac and respiratory vital signs and delivers medication, aiming to monitor, diagnose, and treat life-threatening conditions without wearables or wires.
Deep TechDigital HealthMedical DevicesBrookline, US
Xin Huang(Director)Benjamin Pless(Executive Officer, Director)Carlo Giovanni Traverso(Director)Allan May(Director)
Co-investorsPharmStars Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















